To investigate the utilization of mesh slings for stress urinary incontinence (SUI) across time – before and after the 2011 US Food and Drug Administration (FDA) public health notification regarding an increase in adverse events related to transvaginal mesh (TVM) for pelvic organ prolapse (POP) repair – and among FPMRS-certified urologists and gynecologists and non-FPMRS counterparts using a statewide database.